3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE StudyFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lymphatic Metastasis, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, metastatic malignant neoplasm in the lymph nodes, neoplasm, renal cell carcinoma, rhabdoid tumor of the kidney, sarcomatoid renal cell carcinoma, urinary system disorderActive, not recruitingPhase 32026-10-01NCT03793166
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative CancersNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, atypical teratoid rhabdoid tumor, chordoma, mixed neoplasm, neoplasm, rhabdoid tumor, rhabdoid tumor of the kidney, sarcomaActive, not recruitingPhase 22026-07-01NCT04416568
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, atypical teratoid rhabdoid tumor, chordoma, mixed neoplasm, neoplasm, rhabdoid tumor, rhabdoid tumor of the kidney, sarcomaActive, not recruitingPhase 1 / Phase 22026-04-13NCT05407441